Arye Barak Ben serves as Executive at NovoCure Ltd, where they oversee executive responsibilities. Since joining the company, Arye Barak Ben has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 30, 2025 involved receiving (via award) 769 shares valued at $11.6K.
Arye Barak Ben currently holds 174,465 shares of NovoCure Ltd (NVCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arye Barak Ben has been a net neutral trader of NVCR stock. They have purchased $0 and sold $0 worth of shares.
Arye Barak Ben's most recent insider trade was on Jun 30, 2025, when they sold 769 shares at $15.13 per share.
Get notified when new Form 4 filings are submitted
| $12.24 |
| Discretionary |
| Feb 27, 2024 | NVCR | $1.3M | Award | 81,799 | $16.30 | Discretionary |
| Dec 31, 2023 | NVCR | $1.6K | Award | 128 | $12.69 | Discretionary |
| Jun 30, 2023 | NVCR | $10.2K | Award | 288 | $35.28 | Discretionary |
| Feb 28, 2023 | NVCR | $0 | Award | 17,755 | $N/A | Discretionary |
| Jan 6, 2023 | NVCR | $9.3K | Award | 150 | $62.31 | Discretionary |
| Jul 5, 2022 | NVCR | $8.5K | Award | 144 | $59.08 | Discretionary |